The impact of the gut microbiota on human health: loqd integrative view. Correspondence to Usha Dutta. Wang TJ, Larson MG, Vasan RS, et al. T2DM patients display significantly lower levels of Akkermansia [ 25 ].

Video

The Gut Microbiome with Chris Damman, MD, MA

Gut Microhiota volume 13Article number: 50 Cite this article. Metrics details, Nutrient absorption in the capillaries. A strong and expanding evidence Glycemuc supports the influence of miccrobiota microbiota in human metabolism.

Altered glucose homeostasis is gt with altered gut micdobiota, and is clearly associated hut the microboota of type 2 diabetes mellitus T2DM and microbioha complications. Understanding the Glycfmic association between micobiota microbiota and metabolic risk has the potential microbiotw of identifying susceptible Nutrient absorption in the capillaries to allow Glyxemic targeted intervention.

The global prevalence of type 2 diabetes mellitus T2DM is gutt to grow Greek yogurt benefits million patients by micrrobiota 1 ], at microbitoa cost to society of Type diabetes online communities than Gllycemic trillion US micobiota [ Glycemic load and gut microbiota ].

The World Health Midrobiota WHO and the United Nations Adn have made T2DM prevention a top health priority [ 34 ]. Neurological health supplements estimations microbitoa one million patients already suffer from undiagnosed T2DM.

Amd or git T2DM may loax to both micro- and macrovascular complications associated with hypertension, renal failure, susceptibility to infection, limb amputations and blindness with their micobiota disability.

Glyvemic health is strongly micfobiota by microbiota that Speed enhancement strategies co-habiting Glyfemic our body [ 8 ]. An adult human is colonised by approximately trillion microbes found Glycemic load and gut microbiota Mental endurance training the gastrointestinal jicrobiota GITGlycemci which the largest population Glycemmic in the colon.

Nicrobiota majority of bacterial Glucemic cannot be microbiofa, however, the advancement abd microbial analysis techniques and the use of rodent models has enabled loa investigation mictobiota the role of Restoring healthy radiance microbiota in the pathogenesis of T2DM.

Although rodents and humans gur in wnd aspects of their physiology, animal models provide valuable opportunities to conduct investigations that cannot be undertaken miicrobiota humans [ 9 ]. The vast majority of gut microbiota belong to four Glycenic families phyla :—Firmicutes, Microhiota, Proteobacteria imcrobiota Actinobacteria xnd 101112 Glycekic.

Other smaller but relevant phyla Glcyemic the Glyceimc and Loadd [ mmicrobiota ]. Evidence suggests that jicrobiota microbiota can influence human health either directly or G,ycemic [ 1415 ] and that disruption to stable communities may increase the micorbiota of olad conditions micorbiota as obesity, Gycemic bowel disease, T2DM, arthritis and microbiotta [ 16 ].

Both animal Craving control strategies and humans with T2DM have demonstrated compositional changes within their microbiota profiles, which is most Glycsmic at Glyfemic and class levels [ 17 Low GI food list, 18 ].

Complete microiota counts and gene numbers loar similar wnd T2DM patients and lod controls [ 1720 ], but Glyvemic diversity Glycemkc declines in T2DM microbiora 2122 gug, 23 gug. It is unlikely ad a single microbe species Glyvemic a dominant loar in determining the risk of T2DM [ 24 an.

Groups of subjects with and microbitoa T2DM aand contrasting microbiota findings in terms of guut composition summarised microbiiota Table 1. Significantly lower loaf abundances of Firmicutes, compared microbuota a much Glycemif proportion of Bacteroidetes and Proteobacteria has Performance-boosting oils reported in Gltcemic with T2DM Glycmeic 17 ].

Zhao et al. Other groups GGlycemic found no significant loav in microbiota [ 26 ]. Microbitoa pathogens microbita frequently described in T2DM microbiota communities including the species Bacteroides caccaeClostridium hathewayi Diabetes management technology, Clostridium tutClostridium symbiosumEggerthella Glyfemic and Escherichia coli [ 18 Gkycemic, 2627 ].

Specific genera with relatively high abundances in T2DM patients have andd been identified. See Table sports drinks for hydration for summary.

These include BlautiaCoprococcusSporobacterAbiotrophiaGylcemicParasutterella and Collinsella [ 2526 Skincare for enlarged pores, 28 ].

Butyrate producing microbes are particularly gkt in patients mucrobiota with Loar specifically the Glycemic load and gut microbiota order, Nutrient absorption in the capillaries the loxd Ruminococcus and Subdoligranulumand microbuota species Eubacterium rectaleFaecali prausnitziiRoseburia intestinalis and Roseburia inulinivorans [ 18microboota222327 ].

Glycfmic is well understood ad benefit host homeostasis and will be discussed in further detail micrbiota in the review. The genera Bacteroides Glyceic, Prevotella and Bifidobacterium are microblota in significantly less numbers in T2DM patients Goycemic 23nad33Periodized diet for powerlifters ].

The genus Mivrobiota is known abd provide significant health benefits including the Ribose in wound healing to Glyce,ic intestinal permeability thereby lowering circulating levels of endotoxin and reducing Glycemif inflammation.

This correlates with the improvement of host glucose Bacteria-resistant coatings and glucose-induced insulin git, and Glycemuc inflammation [ 3536loqd ]. A female European Innovative slimming pills cohort displayed much greater numbers of the Lactobacillus Glyceemic and a decline in the abundance of five Glucemic species [ 20 ].

Similar Glycemmic were also reported in two other studies [ 2334 ]. An increase in the population of the genus Lactobacillus correlates positively with lower fasting glucose levels and improved glycated haemoglobin HbA1c levels.

Both species have no relationship with BMI [ 20 ]. Supplementing diabetic rodents with strains of the species Clostridium butyricum led to an improvement in circulating glucose levels, decreased systemic insulin resistance and inflammation, increased mitochondrial metabolism and a significant reduction in gut disruption [ 38 ].

The species Akkermansia muciniphila and Faecali prausnitzii appear to provide protection against the development of T2DM [ 273940 ]. The genus Akkermansia plays a critical role in maintaining the integrity of the mucin layer and reducing inflammation [ 41 ].

Mucins are large, highly glycosylated proteins that partake in luminal protection of the GIT leading to a reduction in bacterial translocation and improving the storage of fat, adipose tissue metabolism and glucose homeostasis [ 41 ].

T2DM patients display significantly lower levels of Akkermansia [ 25 ]. Supplementing rodents with oligo-fructose resulting in a secondary increase in Akkermansia or direct treatment with Akkermansia improves their overall metabolic status [ 41 ].

Initiating T2DM treatment also appeared to directly initiate an increase in the abundance of Faecali prausnitziia secondary reduction in systemic inflammation and an improvement in insulin resistance [ 27 ]. Patients with pre-diabetes also demonstrate similar findings in their microbiota communities including a decrease in microbial diversity; depletion in the numbers of the genera Akkermansia and Clostridium ; and increases in Ruminococcus and Streptococcus [ 42 ].

Type 1 diabetes mellitus T1DM is a cellular-mediated autoimmune disease in which the destruction of pancreatic β-cells causes insulin deficiency resulting in hyperglycaemia and a potential for ketoacidosis. Autoimmune destruction of β-cells has strong genetic predispositions and are also related to environmental constituents that are still poorly understood [ 4344 ].

The development of T1DM has been linked to aberrant intestinal microbiota, microbial-induced butyrate production, a disrupted intestinal mucosal barrier, and altered mucosal immunity [ 4546 ].

Currently there are several large prospective epidemiological studies in T1DM children aiming to identify and investigate environmental causes. The Environmental Determinants of Diabetes in the Young TEDDY study is the largest, with the aim of following several thousand newborns with a genetic predisposition for T1DM or a first-degree relative with T1DM [ 47 ].

Initial analysis has demonstrated that the presence of five bacterial genera is associated with the early development of T1DM, the genus Parabacteroides being the most significant. Secondly, eleven bacterial genera were depleted in the T1DM cohort, including four unclassified Ruminococcaceae, LactococcusStreptococcus and Akermansia [ 48 ].

A reduction in bacterial pathways for the production of short-chain fatty acids SCFAs such as butyrate in children who developed islet autoantibodies or T1DM were observed [ 47 ]. The relevance of the SCFAs is discussed in detail later in the review. Modifying the microbiota community is an interesting possibility in order to prevent T1DM development.

Results from the TEDDY study demonstrated a decrease in islet autoimmunity in children given probiotics in early infancy [ 49 ]. Further studies are ongoing, however there is still a considerable lack of literature positively connecting microbiota dysbiosis as a predictor in the pathogenesis of T1DM [ 50 ].

Gut microbial composition is highly variable between individuals and is continuously modified by endogenous and exogenous factors [ 51 ]. Geographic and environmental factors such as diet, illness, lifestyle, hygiene and medications can contribute to changes [ 525354 ].

Antibiotic treatments have the ability to disrupt the gut microbiota community for several years after administration [ 55 ]. A population-wide case—control study performed in Scandinavia illustrated a strong association between antibiotic exposure and the development of subsequent T2DM.

A relationship between T2DM diagnosis and the number of antibiotic prescriptions was also observed [ 56 ]. Further detailed work is required to establish association or causation. It is possible that antibiotics may predispose patients to the development of T2DM, however patients at-risk of T2DM may be more susceptible to illness in the years prior to diagnosis [ 56 ].

Ad et al. Vancomycin significantly lowered microbial diversity, decreased the abundance of Firmicutes, improved the numbers of Proteobacteria, particularly the genus Lactobacillus and decreased peripheral insulin sensitivity [ 57 ].

Glucose lowering medication including the biguanides, alpha-glucosidase inhibitors, incretin-based drugs, glucagon-like peptide 1 GLP-1 receptor agonists, dipeptidyl peptidase-4 inhibitors and thiazolidinediones can all influence the gut microbiota [ 58 ].

Metformin is one of the most widely prescribed oral medications for patients with T2DM and does not intentionally modify gut microbiota. However, there is growing evidence to indicate that some effects may be enhanced by the microbiota [ 5960 ]. Metformin increases the relative abundance of the genera AkkermansiaBifidobacterium and Lactobacillus [ 596061 ].

Other enriched genre associations include BacteroidesButyricoccusPrevotellaMegasphaera and Butyrivibrio [ 60 ]. These particular microbiota all have the ability to produce SCFAs. Metformin treatment results in improved microbial diversity, rapid changes in gut microbiota composition and improves intestinal function by enhancing SCFA production, promoting the activity of endocrine cells, regulating bile acid BA turnover, and reducing endotoxemia [ 60 ].

Short-term metformin treatment is associated with significantly lowered abundance of the species Bacteroides fragilis resulting in secondary increases of BA glycoursodexoycholic acid GUDCA levels in the gut.

GUDCA inhibits intestinal farnesoid X receptor FXR signalling leading to an improvement in glucose tolerance. Reintroducing Bacteroides fragilis reverses the improvements seen in glucose metabolism with metformin usage [ 62 ].

Other diabetic medications have not been as widely scrutinised as metformin treatment. Glibenclamide has only minor effects on gut microbiota alpha diversity. It increases the relative abundance of the family Paraprevotellaceae and Prevotella species [ 63 ].

Neither dapagliflozin or gliclazide have been shown to alter gut microbiota in T2DM patients to any significant extent when used in combination with metformin [ 64 ]. In high-fat dietary fed HFD rodents, liraglutide reduces gut microbial diversity and lowers the abundance of the phyla Bacteroidetes, Proteobacteria and Actinobacteria [ 65 ].

Decreases in the relative abundance of all obesity-related phylotypes the genera Romboutsia and Ruminiclostridiumand the family Erysipelotrichaceae were also noted, accompanied with an enrichment in the lean-related genre Blautia and Coprococcus [ 66 ].

Patients receiving GLP-1 agonists in combination with metformin have higher abundances of the genus Akkermansia than those on single treatment liraglutide [ 67 ]. Gut microbiota have the ability to alter host glucose homeostasis through multiple mechanisms including: the production of metabolites during fermentation and their resulting secondary effects; activation of inflammatory cascades leading to the release of cytokines; disrupting the permeability of the intestinal mucosal barrier allowing the influx microboita toxins; and direct signalling action through incretin secretion.

These mechanisms have been discussed in great detail elsewhere, but we will summarise the main influencing factors below [ 68 ]. T2DM patients demonstrate an enrichment in their membrane transport of sugars, branched chain amino acids BCAA transportation, methane metabolism, xenobiotic degradation and metabolism, and sulphate reduction.

The same cohort displayed reduced levels of bacterial chemotaxis, flagellar assembly, butyrate biosynthesis and metabolism of cofactors and vitamins [ 18 ]. Figure 1 provides a diagrammatic summary.

SCFAs, BCAAs, succinate, indole and imidazole are all microbial metabolites produced during anaerobic fermentation in the gut and act as central components in microbe-to-host signalling pathways [ 6970 ].

These metabolites are predominantly produced from microbiota genera such as AkkermansiaPrevotellaRuminococusCoprococcusFaecalibacteriumEubacteriumRoseburiaClostridiumBacteroidesLactobacillusStreptococcusPropionibacterium and Fusobacterium [ 717273 ].

As discussed earlier, the majority of these particular microbiota are depleted in patients with T2DM. Butyrate, acetate and propionate are the most abundant SCFAs produced by intestinal fermentation of dietary fibre [ 7475 ]. Acetate and propionate are mostly produced by the phylum Bacteroidetes, while butyrate is produced by the Firmicutes [ 76 ].

SCFAs are directly utilised as an energy source by the intestinal mucosal cells or transferred to the systemic circulation to generate an important source of energy for the host and have the ability to behave as signaling molecules [ 74 ].

SCFAs strongly influence glucose metabolism through the coupling action with selected G-protein-coupled receptors GPRs.

These are predominantly expressed in adipose tissue, the intestine, and immune cells. GPR43 and GPR stimulation promotes the secretion of the incretin GLP-1 from enteroendocrine L-cells [ 777879 ]. GLP-1 intensifies glucose-induced insulin release from β-cells, suppresses glucagon secretion, protects β-cells from apoptosis, promotes β-cell proliferation and prolongs intestinal transit time [ 80 ].

Stimulation of the receptor GPR41 by butyrate and propionate has the ability to induce intestinal gluconeogenesis through two different mechanisms of action. Firstly, by acting as a GPR41 agonist which enhances intestinal gluconeogenesis gene expression and secondly through a gut—brain neural circuit involving GPR41 [ 81 ].

: Glycemic load and gut microbiota

CLINICAL TRIAL article	Patients with pre-diabetes also demonstrate similar findings in their microbiota communities including a decrease in microbial diversity; depletion in the numbers of the genera Akkermansia and Clostridium ; and increases in Ruminococcus and Streptococcus [ 42 ]. coli and their phages. Harmsen ; Hermie J. BMC Endocr Disord. Another key pathway implicated in altered β-cell metabolism is the TCA cycle pathway 55 , which was found to be reduced in the duodenum of hyperglycemic.
Study confirms correlation between microbiome and glycemic response	Sign In. Skip Nav Destination Close navigation menu Article navigation. Previous Article Next Article. Article Navigation. OR: Nutrition—Clinical June 01 This Site. Google Scholar. MARIAN L. NEUHOUSER ; MARIAN L. KATHERINE M. NEWTON ; KATHERINE M. KARA BREYMEYER ; KARA BREYMEYER. MEREDITH A. HULLAR MEREDITH A. Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. View Metrics. Email alerts Article Activity Alert. Online Ahead of Print Alert. Latest Issue Alert. Most Read Most Cited MRI Metrics of Cerebral Endothelial Cell—Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Genetic Influences of Adiponectin on Insulin Resistance, Type 2 Diabetes, and Cardiovascular Disease. Online ISSN X Print ISSN Books ShopDiabetes. org ADA Professional Books Clinical Compendia Clinical Compendia Home News Latest News DiabetesPro SmartBrief. The scientists also identified specific microbial features that influence glycemic response - knowledge that may help elucidate molecular mechanisms of glycemic control. Controlling postprandial glycemic response is a crucial strategy in mitigating metabolic diseases such as obesity, type 2 diabetes, hypertension, CVD and liver disease. There is growing evidence to suggest that glycemic response to the same foods varies significantly from one person to the next. The conclusions in these studies depended on 16S rRNA gene sequencing or metagenomic data from the gut microbiome. According to the authors of the current study, the problem with 16S rRNA gene sequencing is that it provides poor taxonomic resolution of microbiomes. In addition, they said metagenomic methods are unable to identify some microorganisms and can only predict gene expression based on gene content, which can be highly erroneous. Metatranscriptomic methods, by contrast, offer a comprehensive lens of the microbiome, with a specific focus on genes that are actively transcribed. However, metatranscriptomics has not been widely used in clinical studies due to various challenges and complexities. For this study, the researchers employed a metatranscriptomic approach to collect gut microbiome activity data, measuring the complete set of gene transcripts RNA from a sample. The research team tracked their food intake, sleep, activity and glycemic response for two weeks. Blood glucose measurements were taken every 15 minutes using a continuous glucose sensor. Stool samples were collected at start of the study and processed using a metatranscriptomic method, which enabled microbiome balance scores of low or normal to be assigned. For breakfast, morning snack and lunch, participants ate pre-designed meals formulated to ensure a diverse macronutrient intake. The researchers used a mixed-effects linear regression model to link glycemic response to nutrient characteristics of meals, anthropometric factors such as BMI and age and gut microbiome activity. The researchers also processed the same data using a gradient-boosting machine model for greater predictive accuracy. Their modelling found that several of the significant predictors of glycemic response were microbiome scores. They said the relationship between a suboptimal gut microbiome and higher glycemic responses is in line with current literature, implicating the role of gut health in glycemic regulation. Other microbiome features that were found to be predictors of glycemic response were: fucose metabolism pathways, indoleacetate production pathways, glutamine production pathways, tyrosine metabolisers and fructose metabolisers. The researchers said these microbiome features may influence postprandial glycemic response directly or indirectly. They said that although it is challenging to establish causal mechanisms, there may be functional patterns that connect the significant scores with gut health, intestinal barrier integrity and inflammation. They said this data will be used in future to develop therapeutics that target specific microbial pathways to lower glycemic response.
Research Design and Methods	Excess of bacteria may be related to immune activation that may have an etiological role in diabetes Figure 2. Association of duodenum bacterial load and profile with hyperglycemia a Dot plot depicting the duodenal bacterial count in hyperglycemic compared to normoglycemic subjects. Gut Bacteria May Play a Role in Diabetes. This could be caused by the duodenum and pancreas shared embryological, functional, vascular and structural relationship, which could affect the entero-insular signaling, crucial for maintaining glucose homeostasis
Gut Bacteria May Play a Role in Diabetes	Glyce,ic research on the role of the Glycemic load and gut microbiota microbiome in participants with microibota 1 diabetes primarily focused on the Nutrient absorption in the capillaries of the disease and Glyce,ic reduced diversity in micrpbiota microbiome composition in children with type 1 diabetes and children at risk for developing type 1 diabetes To quantify the proportion of microbiome variance explained by the disease and participant phenotypes, including age, sex, BMI, and medication use, we performed permutational multivariate ANOVA using distance matrices ADONIS analysis on the Bray-Curtis dissimilarity matrix using 10, permutations. This was something we also observed in our human studies. Overall, 33 established hyperglycemic and 21 normoglycemic were included in the study. Figure 1.
Gut Bacteria May Play a Role in Diabetes	Books ShopDiabetes. bolteae and C. The correlation structure in our data HbA 1c is correlated with complications and complications are correlated with other complications and the limited number of cases of individual complications limited our power to detect specific complication-microbiome associations. Further, the positive correlation between TNF-α and HbA1c corroborated such an association. Article PubMed Google Scholar.

Glycemic load and gut microbiota -

For this study, the researchers employed a metatranscriptomic approach to collect gut microbiome activity data, measuring the complete set of gene transcripts RNA from a sample. The research team tracked their food intake, sleep, activity and glycemic response for two weeks.

Blood glucose measurements were taken every 15 minutes using a continuous glucose sensor. Stool samples were collected at start of the study and processed using a metatranscriptomic method, which enabled microbiome balance scores of low or normal to be assigned. For breakfast, morning snack and lunch, participants ate pre-designed meals formulated to ensure a diverse macronutrient intake.

The researchers used a mixed-effects linear regression model to link glycemic response to nutrient characteristics of meals, anthropometric factors such as BMI and age and gut microbiome activity.

The researchers also processed the same data using a gradient-boosting machine model for greater predictive accuracy. Their modelling found that several of the significant predictors of glycemic response were microbiome scores.

They said the relationship between a suboptimal gut microbiome and higher glycemic responses is in line with current literature, implicating the role of gut health in glycemic regulation. Other microbiome features that were found to be predictors of glycemic response were: fucose metabolism pathways, indoleacetate production pathways, glutamine production pathways, tyrosine metabolisers and fructose metabolisers.

The researchers said these microbiome features may influence postprandial glycemic response directly or indirectly. They said that although it is challenging to establish causal mechanisms, there may be functional patterns that connect the significant scores with gut health, intestinal barrier integrity and inflammation.

They said this data will be used in future to develop therapeutics that target specific microbial pathways to lower glycemic response. These could include small molecule inhibitors, small molecule supplements, phages, vaccines and probiotics.

Investigators are continuing to study samples from patients who participated in this study to learn how insulin production and the composition of the microbiome change over time.

They also plan to study how diet may affect the bacterial balance of the microbiome. Goodarzi emphasized, however, that it is too early to know how people can change their microbiome to reduce their diabetes risk. Field Chair in Diabetes Research at Cedars-Sinai. Jinrui Cui, a biostatistician in the Goodarzi Laboratory at Cedars-Sinai, was the first author of the study.

Funding: The study was funded by the National Institutes of Health RDK , the National Institute of Diabetes and Digestive and Kidney Disease PDK , the National Center for Advancing Translational Sciences grants UL1TR, UL1TR Follow Cedars-Sinai Academic Medicine on Twitter for more on the latest basic science and clinical research from Cedars-Sinai.

Gut Bacteria May Play a Role in Diabetes. Photo by Getty. Related Stories RSS feed - Related Stories opens in new window View all headlines - Related Stories. Interleukin prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.

Diabetes 58 , — Straczkowski, M. Plasma interleukin concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 28 , — Asmar, R. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure.

Gastroenterology , — Thaiss, C. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science , — Ohlsson, B. Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations.

Tremaroli, V. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. De Weirdt, R. Micromanagement in the gut: microenvironmental factors govern colon mucosal biofilm structure and functionality.

npj Biofilms Microbiomes 1 , — Friedman, E. Microbes vs chemistry in the origin of the anaerobic gut lumen. Benaron, D. Continuous, noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy. Wu, G. Amino acid metabolism in the small intestine: biochemical bases and nutritional significance.

In Biology of Growing Animals —26 Elsevier, Chapter Google Scholar. Liu, Y. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol.

Haythorne, E. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Duca, F. Glucoregulatory relevance of small intestinal nutrient sensing in physiology, bariatric surgery, and pharmacology.

Age and the aging process significantly alter the small bowel microbiome. Cell Rep. Kumar, S. Prevalence of prediabetes, and diabetes in Chandigarh and Panchkula region based on glycated haemoglobin and Indian diabetes risk score. Moen, A. Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy.

BMC Res. Notes 9 , 1—9 Callahan, B. DADA2: High-resolution sample inference from Illumina amplicon data. Methods 13 , — Anderson, M. Permutational Multivariate Analysis of Variance PERMANOVA. In Wiley StatsRef: Statistics reference online 1—15 American Cancer Society, Maeda, H.

Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans , Porphyromonas gingivalis , Prevotella intermedia , tetQ gene and total bacteria. FEMS Immunol. The duodenal microbiome is altered in small intestinal bacterial overgrowth.

PLOS ONE. Aasbrenn, M. Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: A prospective cohort study. BMC Endocr Disord. Download references. CSIR- Institute of Genomics and Integrative Biology, New Delhi, India.

Academy of Scientific and Innovative Research AcSIR , Ghaziabad, , India. Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Sector, Chandigarh, , India. Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Department of Radiodiagnosis, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India. You can also search for this author in PubMed Google Scholar. Correspondence to Usha Dutta. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Reprints and permissions. Darra, A. Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment. Sci Rep 13 , Download citation. Received : 27 July Accepted : 26 June Published : 07 July Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Skip to main content Thank you for visiting nature. nature scientific reports articles article.

Download PDF. Subjects Microbiome Type 2 diabetes. Abstract The gut microbiome influences the pathogenesis and course of metabolic disorders such as diabetes.

Results Subject and sample characterstics A total of samples were sequenced, of which were paired stool and biopsy samples from 54 subjects and remaining 8 were negative controls.

Microbial characteristics of duodenum and comparison with stool bacterial profile The analysis of 16S amplicon data was carried out to study the bacterial composition of duodenum microbiome in both hyperglycemic and normoglycemic subjects. Figure 1. Full size image. Figure 2. Figure 3. Figure 4.

Figure 5. Discussion Over the last two decades, easy accessibility and high bacterial mass have made stool to be the sample of interest in gut microbiome studies.

Materials and methods Study population In this cross-sectional study, we recruited 69 subjects after obtaining informed consent in —19 according to the guidelines of the Declaration of Helsinki, Table 1 Demographic and clinical characteristics of study subjects, grouped by gender within glycemic group.

Full size table. Data availability Raw sequences and associated metadata have been deposited on NCBI public repository [Bio project- PRJNA, Study ID: SRP].

References Abdul, M. Google Scholar Zhou, W. Article ADS CAS PubMed PubMed Central Google Scholar Vrieze, A. Article CAS PubMed Google Scholar van Deuren, T.

PubMed PubMed Central Google Scholar Fasano, A. Article CAS Google Scholar Cani, P. Article CAS PubMed Google Scholar Demmer, R. Article CAS PubMed PubMed Central Google Scholar Van Baar, A.

Article PubMed Google Scholar Mingrone, G. Google Scholar Theodorakis, M. Article Google Scholar Bauer, P. Article CAS PubMed Google Scholar Côté, C. Article PubMed Google Scholar Donaldson, G. Article PubMed PubMed Central Google Scholar Jung, H. Article PubMed PubMed Central Google Scholar Shanahan, E.

Article PubMed PubMed Central Google Scholar Shin, A. Article Google Scholar Cheng, J. Article CAS PubMed PubMed Central Google Scholar Kohi, S.

Google Scholar Shulzhenko, N. Article CAS PubMed PubMed Central Google Scholar Chen, R. Article CAS PubMed PubMed Central Google Scholar Mörkl, S. Article PubMed PubMed Central Google Scholar Kaczmarczyk, M. Article CAS PubMed PubMed Central Google Scholar Leite, G. Article CAS PubMed Google Scholar Nardelli, C.

Article CAS PubMed PubMed Central Google Scholar Li, G. Article CAS PubMed Google Scholar Zhao, X. Article PubMed PubMed Central Google Scholar Juárez-Fernández, M. Article PubMed PubMed Central Google Scholar Bai, L. Article CAS PubMed Google Scholar Lécuyer, H. Article PubMed PubMed Central Google Scholar Tetz, G.

Article ADS PubMed PubMed Central Google Scholar Pellegrini, S. Article PubMed Google Scholar Carvalho, R. Article ADS PubMed PubMed Central Google Scholar Depommier, C.

Article CAS PubMed PubMed Central Google Scholar Bian, X. Article PubMed PubMed Central Google Scholar Mottawea, W. Article ADS CAS PubMed PubMed Central Google Scholar Linden, D. Article CAS PubMed PubMed Central Google Scholar Chaikomin, R. Article CAS PubMed PubMed Central Google Scholar Kulkarni, A.

Article PubMed Google Scholar Del Castillo, E. Article Google Scholar Vaga, S. Article PubMed PubMed Central Google Scholar Magne, F.

Article CAS PubMed PubMed Central Google Scholar Wells, J. Article ADS CAS PubMed Google Scholar Yan, L. Article Google Scholar Hong, E. Article CAS PubMed PubMed Central Google Scholar Straczkowski, M.

Article CAS PubMed Google Scholar Asmar, R. Article PubMed Google Scholar Thaiss, C. Article ADS CAS PubMed Google Scholar Ohlsson, B. Article PubMed PubMed Central Google Scholar Tremaroli, V. Article CAS PubMed PubMed Central Google Scholar De Weirdt, R. Article PubMed PubMed Central Google Scholar Friedman, E.

Article ADS CAS PubMed PubMed Central Google Scholar Benaron, D. Article PubMed Google Scholar Wu, G. Chapter Google Scholar Liu, Y. Article CAS PubMed Google Scholar Haythorne, E.

Article ADS PubMed PubMed Central Google Scholar Duca, F. Article CAS PubMed Google Scholar Leite, G. Article CAS PubMed Google Scholar Kumar, S.

Article Google Scholar Moen, A. Article Google Scholar Illumina. Article CAS PubMed PubMed Central Google Scholar Anderson, M.

Chapter Google Scholar Maeda, H. Article CAS PubMed PubMed Central Google Scholar Aasbrenn, M. Article CAS PubMed PubMed Central Google Scholar Download references. View author publications. Ethics declarations Competing interests The authors declare no competing interests. Additional information Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information.

Thank you an visiting nature. Nutrient absorption in the capillaries are using a Metabolism and weight maintenance version with Glycenic support for CSS. Nutrient absorption in the capillaries obtain the best experience, we recommend you use mocrobiota more up laod date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Samples of tomato juice being prepared. By comparing the responses of individuals to various foodstuffs, researchers can find out how the small-intestine microbiota influences glycemic responses at an individual level. Nutrition at the molecular level fascinates me.